Common antidepressant may ease long COVID’s crushing fatigue
1 week ago
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
phone_android📱 Use Epelcon on Your PhoneFaster. Always with you. Install the new Epelcon Mobile App v3.1.0 and access all 19 modules from your Android phone — Wallet, Jobs, Property, Diet Plans, Courses, Blog & more.Get the App
Advertise With Us!
Promote your brand, products or services across our homepage, shop, blog, email newsletters & social media channels.
This website uses cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking “Accept”, you consent to our use of cookies.